Business Context and Reporting Period
This Form 8-K is a current report filed by Becton, Dickinson and Company (BD) on March 28, 2022. The filing primarily addresses executive leadership changes within the Medical segment and the associated compensatory arrangements.
Key Financial Metrics
This filing does not contain comprehensive financial statements, revenue, profit, cash flow, or margin data. The only specific financial figure disclosed relates to executive compensation:
- Retention Award: A one-time cash award of $300,000 is to be paid to Alberto Mas, contingent upon his continued active employment through September 30, 2022.
Material Changes
The material event reported is the announced retirement of Alberto Mas, Executive Vice President and President of the Medical segment. His retirement is effective at the end of BD's fiscal year on September 30, 2022. The company intends to name a successor prior to this date.
Outlook, Risks, and Management Commentary
Management has initiated a succession process to support a smooth transition. A press release detailing these matters was issued on March 31, 2022, and is attached as Exhibit 99.1. The filing notes that the information in the press release is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the timeline for the appointment of Alberto Mas's successor.
- Review the attached press release (Exhibit 99.1) for additional details on the transition plan.
- Confirm the impact of this leadership change on the Medical segment's strategic direction in upcoming quarterly reports.